North America Direct-to-Consumer Genetic Testing Market to 2030 - By Size, Share, Growth by End User and Forecast

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. North America Direct-to-Consumer Genetic Testing Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. North America Direct-to-Consumer Genetic Testing Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Increasing incidence of genetic disorders

5.2 Market Opportunities

5.2.1 New Product Launches by Companies is likely to Create Opportunities in Future Years for the overall Market

5.3 Future Trends

5.3.1 Rising public awareness of direct-to-consumer genetic testing

5.4 Impact of Drivers and Restraints

6. North America Direct-to-Consumer Genetic Testing Market Regional Analysis

6.1 North America Direct-to-Consumer Genetic Testing Market Overview

6.2 North America Direct-to-Consumer Genetic Testing Market Revenue 2020-2030 (US$ Million)

6.3 North America Direct-to-Consumer Genetic Testing Market Forecast Analysis

7. North America Direct-to-Consumer Genetic Testing Market Analysis – by Test Type

7.1 Ancestry Testing

7.1.1 Overview
7.1.2 Ancestry Testing: North America Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Predictive Testing

7.2.1 Overview
7.2.2 Predictive Testing: North America Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Nutrigenomics Testing

7.3.1 Overview
7.3.2 Nutrigenomics Testing: North America Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Carrier Testing

7.4.1 Overview
7.4.2 Carrier Testing: North America Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Direct-to-Consumer Genetic Testing Market Analysis – by Technology

8.1 Whole Genome Sequencing

8.1.1 Overview
8.1.2 Whole Genome Sequencing: North America Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)

8.2 Single Nucleotide Polymorphism Chips

8.2.1 Overview
8.2.2 Single Nucleotide Polymorphism Chips: North America Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)

8.3 Targeted Analysis

8.3.1 Overview
8.3.2 Targeted Analysis: North America Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Direct-to-Consumer Genetic Testing Market Analysis – by Distribution Channel

9.1 Online

9.1.1 Overview
9.1.2 Targeted Analysis: North America Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)

9.2 Offline

9.2.1 Overview
9.2.2 Targeted Analysis: North America Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Direct-to-Consumer Genetic Testing Market – North America Analysis

10.1 North America

10.1.1 North America Direct-to-Consumer Genetic Testing Market Breakdown, by Key Country, 2023 and 2030 (%)
10.1.1.1 North America Direct-to-Consumer Genetic Testing Market – Revenue and Forecast Analysis – by Country
10.1.1.1 US: North America Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.1.1 US: North America Direct-to-Consumer Genetic Testing Market Breakdown, by Test Type
10.1.1.1.2 US: North America Direct-to-Consumer Genetic Testing Market Breakdown, by Technology
10.1.1.1.3 US: North America Direct-to-Consumer Genetic Testing Market Breakdown, by Distribution Channel

10.1.1.2 Canada: North America Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.2.1 Canada: North America Direct-to-Consumer Genetic Testing Market Breakdown, by Test Type
10.1.1.2.2 Canada: North America Direct-to-Consumer Genetic Testing Market Breakdown, by Technology
10.1.1.2.3 Canada: North America Direct-to-Consumer Genetic Testing Market Breakdown, by Distribution Channel

10.1.1.3 Mexico : North America Direct-to-Consumer Genetic Testing Market – Revenue and Forecast to 2030 (US$ Million)

10.1.1.3.1 Mexico : North America Direct-to-Consumer Genetic Testing Market Breakdown, by Test Type
10.1.1.3.2 Mexico : North America Direct-to-Consumer Genetic Testing Market Breakdown, by Technology
10.1.1.3.3 Mexico : North America Direct-to-Consumer Genetic Testing Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. North America Direct-to-Consumer Genetic Testing Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Ancestry Genomics Inc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Color Health Inc

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Helix Inc

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 Myriad Genetics, Inc.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Living DNA Ltd

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 23andMe Inc

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Genetic Technologies Ltd

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 Gene By Gene Ltd

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 Full Genomes Corp Inc

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights